It's a disease that is most common in people in their 70s, more common in women, and almost never seen below the age of 50.

I was recently diagnosed with polymyalgia rheumatica after weeks of intense muscle pain. I’m a 67-year-old female in otherwise good health. My doctor prescribed prednisone, which immediately ...

Laboratory testing for inflammation, such as the C-reactive protein test and the erythrocyte sedimentation rate, are almost ...

Dear Dr. Roach: I’m a 75-year-old male in good health. I’ve been on blood thinners since 1998. For years, I had been on ...

Edoxaban was at least as effective as warfarin in preventing thromboembolism after bioprosthetic valve replacement in the ...

In the ENBALV study, it was inconclusive whether edoxaban is a better treatment than warfarin for patients with early ...

CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) is a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible ...

There was also almost a tripling of the risk of anaemia caused by bleeding. The researchers looked at several types of blood ...

Unlike warfarin, the standard treatment, edoxaban does not require regular monitoring of blood clotting activity and doesn't ...

Dr Eric Berg DC, who is known as The Knowledge Doc, has shared the 'amazing benefits' of taking half a teaspoon of a ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...

Cadrenal aims to develop a better VKA blood thinner for these warfarin-dependent patients. In addition to receiving the award, Cadrenal was featured in the current edition of Pharma Tech Outlook.